The glycosphingolipidoses are a set of diseases that are caused by defects
in the lysosomal degradation of glycolipids derived from the plasma membran
e. By investigating the molecular bases of the diseases, basic principles o
f storage disease pathology and of membrane digestion were discovered. The
generation of mouse models has facilitated the development of new and promi
sing therapeutic strategies for these diseases, most of which are not treat
able at present. Lately, the discovery of the importance of glycosphingolip
id metabolism for skin development has opened a new and interesting field.